| Makale Türü |
|
||
| Dergi Adı | Rsc Advances (Q2) | ||
| Dergi ISSN | 2046-2069 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | İngilizce | Basım Tarihi | 01-2026 |
| Cilt / Sayı / Sayfa | 16 / 2 / 1662–1681 | DOI | 10.1039/d5ra08761a |
| Makale Linki | https://doi.org/10.1039/d5ra08761a | ||
| UAK Araştırma Alanları |
Organik Kimya
|
||
| Özet |
| The present study aimed to investigate the antidiabetic potential of a new series of thiosemicarbazone derivatives through integrated in vitro enzymatic assays and in silico molecular modeling. The synthesized compounds were evaluated for their inhibitory activities against α-glucosidase (α-Glu) and α-amylase (α-Amy) enzymes. Among the tested derivatives, compound 16 (2-chlorophenyl-substituted) demonstrated the most potent dual inhibition with IC50 values of 14.58 nM (α-Glu) and 88.37 nM (α-Amy), surpassing the reference drug acarbose in potency. Molecular docking analyses revealed that compound 16 formed stable interactions with Asn-214, Glu-276, Phe-157, and Tyr-71 in the α-Glu and Asp-197, Glu-233, and Lys-200 in α-Amy's active site. These key interactions were further supported by 250 ns molecular dynamics simulations, confirming the conformational stability of both complexes with average … |
| Anahtar Kelimeler |
| Atıf Sayıları | |
| Web of Science | 6 |
| Scopus | 6 |
| Google Scholar | 6 |
| Dergi Adı | RSC Advances |
| Yayıncı | Royal Society of Chemistry |
| Açık Erişim | Evet |
| E-ISSN | 2046-2069 |
| CiteScore | 7,6 |
| SJR | 0,777 |
| SNIP | 0,964 |